Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended Release Triamcinolone for Rotator Cuff Disease
NCT04094298Phase 3Terminated
- Sponsor
- Northwell Health
- Start
- Aug 2020
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
A Phase 3 trial of triamcinolone acetonide in rotator cuff disease, sponsored by Northwell Health. Started Aug 2020; status: terminated.
02
Drugs
triamcinolone acetonide
03
Conditions
rotator cuff disease
Beyond the preview
Go deeper on NCT04094298.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094298.